Hamostaseologie 1985; 05(01): 42-43
DOI: 10.1055/s-0038-1655098
Originalarbeiten
Schattauer GmbH

Heparin

Ein neues Konzept seiner Natur und seiner Wirkung • Teil I
L. B. Jaques
1   Abteilung für Stomatobiologie, College für Zahnheilkunde der Universität von Saskatchewan, Saskatoon, Saskatchewan, Kanada
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

 

 
  • LITERATUR

  • 1 Bayliss W. M. Principles of General Physiology. 1st. ed. Longman and Green; New York: 1915: 703.
  • 2 Charles A. F, Scott D. A. Studies on Heparin. I. The preparation of heparin. J. biol. Chem. 102: 424-431 1933; II. Heparin in various tissues. Ibd. 432-436 (1933). III. The purification of heparin. Ibd. 437-448 (1933).
  • 3 Murray D. W. G, Jaques L. B, Perrett T. S, Best C. H. Heparin and the thrombosis of veins following injury. Surgery 02: 163-187 1937;
  • 3a Murray D. W. G, Best C. H. The use of heparin in thrombosis. Ann. Surg. 108: 163-173 1938;
  • 4 Bergstrom S, Jorpes E, Wilander O. Studies on pure heparin. Scand. Arch. Physiologie. 76: 175-185 1937;
  • 5 Jorpes E. Heparin. 1st edition. Oxford University Press; London: 1939
  • 6 Jaques L. B. The action of heparin in vivo. M. A. Thesis. Univ. of Toronto; Toronto, Canada: May 1935
  • 7 Bergstrom S. Über Polysaccharide-ester- schwefelsäuren mit Heparinwirkung. Z. Physiol. Chem. 238: 163-168 1936;
  • 8 Jaques L. B. The heparins of various mammalian species and their anticoagulant potency. Science 92: 488-489 1940;
  • 9 Fischer A. Die Bindung von Heparin an Eiweiß. Biochem. Z. 278: 133-160 1935;
  • 10 Jaques L. B. Addendum: The Discovery of Heparin. Sem. in Thromb. and Haemost. 04: 350-354 1978;
  • 11 Jaques L. B, Kavanagh L. W, Laval-lee A. A comparison of biological activities and chemical analyses for various heparin preparations. Arzneimittelforschung 17: 774-778 1967;
  • 11a Jaques L. B, Kavanagh L. W, Kuo S. H. Variation in chemical parameters and anticoagulant potencies of commercial heparin and its relation to the problem of heparin standardized for clinical use. Thromb. Res. 03: 295-306 1973;
  • 12 Lippman M, Mathews M. B. Heparins: Varying effects on cell proliferation in vitro and lack of correlation with anticoagulant activity. Fed. Proc. 36: 55-59 1977;
  • 13 Jaques L. B, McDuffie N. M. The chemical and anticoagulant nature of heparin. Sem. in Thrombosis and Hemostasis. -4: 277-297 1978;
  • 14 Jaques L. B, Mahadoo J. M. Pharmacodynamics and clinical effectiveness of heparin. Sem. in Thrombosis and Hemostasis. 04: 298-325 1978;